drugset / Trial / NCT01633788
A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety and efficacy of AGN-195263 compared to vehicle in patients with meibomian gland dysfunction (MGD) in the eyelids.
Timeline
- Start
- 2012-08-22
- Primary completion
- 2015-02-05
- Completion
- 2015-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGN-195263 | Unknown | 0.01 % | Other |
| Subject | AGN-195263 | Unknown | 0.03 % | Other |
| Subject | AGN-195263 | Unknown | 0.1 % | Other |